KIR3DS1 directs NK cell–mediated protection against human adenovirus infections
Johannes M. Jung, Madeleine J. Bunders(Leibniz Institute of Virology (LIV)), Tobias Koyro(Leibniz Institute of Virology (LIV)), Kevin Duisters(Leiden University), Anja Ehrhardt(Witten/Herdecke University), Suze A. Jansen(Utrecht University), Eric Spierings(University Medical Center Utrecht), Marcus Altfeld(Harvard University), Martin E. Baumdick(Max Planck Institute of Molecular Physiology), Konrad Reinshagen, Wilhelm Ching(Leibniz Institute of Virology (LIV)), Annika Niehrs(Karolinska University Hospital), Caroline A. Lindemans(University Medical Center Utrecht), Kimberly J. Möller(Leibniz Institute of Virology (LIV)), Lucy H.M. Wegner(Leibniz Institute of Virology (LIV)), Thomas Dobner(Leibniz Institute of Virology (LIV)), Helga Hofmann-Sieber(Leibniz Institute of Virology (LIV)), Angelique Hölzemer(Leibniz Institute of Virology (LIV)), Daniel Pérez(Universität Hamburg), Wenli Zhang(Witten/Herdecke University), Ingo Königs(Kinderkrebs-Zentrum Hamburg), Kristina Russu(Leibniz Institute of Virology (LIV)), Mareike Ohms, Mirjam E. Belderbos(Princess Máxima Center), Sven Peine(Universität Hamburg), Christian Körner(Heidelberg University), Marc Lütgehetmann(Universität Hamburg), Jens B. Bosse(Leibniz Institute of Virology (LIV))
Cited by 18
Related Papers
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
|Annals of Internal Medicine|2020|2.4k
Multiorgan and Renal Tropism of SARS-CoV-2
|New England Journal of Medicine|2020|1.9k
Neuropathology of patients with COVID-19 in Germany: a post-mortem case series
|The Lancet Neurology|2020|1.4k